Research Analysts Set Expectations for RVPH Q2 Earnings
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Free Report) – Research analysts at Roth Capital lifted their Q2 2025 earnings estimates for Reviva Pharmaceuticals in a note issued to investors on Monday, May 19th. Roth Capital analyst B. Pachaiyappan now expects that the company will post earnings per share of ($0.09) for the quarter, up from […]
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Free Report) – Research analysts at Roth Capital lifted their Q2 2025 earnings estimates for Reviva Pharmaceuticals in a note issued to investors on Monday, May 19th. Roth Capital analyst B. Pachaiyappan now expects that the company will post earnings per share of ($0.09) for the quarter, up from […]
